VALNEVA (EPA:VLA) | Finanzwire

BRIEF

published on 02/05/2025 at 07:05, 1 month 9 days ago

Valneva Achieves UK Approval for World's First Chikungunya Vaccine

Public Health Valneva Chikungunya Vaccine UK Approval Travel Safety
PRESS RELEASE

published on 02/05/2025 at 07:00, 1 month 9 days ago

Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
Valneva receives marketing authorization in the UK for the world's first chikungunya vaccine, IXCHIQ®. Single-dose vaccine for individuals 18+ provides rapid and strong immune response

UK Valneva MHRA Chikungunya Vaccine IXCHIQ®
BRIEF

published on 12/05/2024 at 07:35, 3 months 9 days ago

Valneva Reports Share and Voting Rights as of November 30, 2024

Euronext Paris Share Capital Voting Rights Valneva Double Voting
PRESS RELEASE

published on 12/05/2024 at 07:30, 3 months 9 days ago

VALNEVA - Declaration of shares and voting rights: November 30, 2024
VALNEVA declares transfer of 1,000 shares into bearer form with double voting rights on November 26, 2024. Total voting rights: 178,371,727

Euronext Paris Voting Rights Shares Stock Market Valneva
BRIEF

published on 12/04/2024 at 10:02, 3 months 10 days ago

Polar Capital reduces its stake in VALNEVA SE

Voting Rights Actions Valneva SE Threshold Crossing Polar Capital
BRIEF

published on 12/04/2024 at 07:05, 3 months 10 days ago

Valneva Publishes Findings on Chikungunya Impact in British Medical Journal

Climate Change Chikungunya Health Impact Economic Burden Global Study
PRESS RELEASE

published on 12/04/2024 at 07:00, 3 months 10 days ago

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal
Valneva SE announces the publication of an article on the global health and economic burden of chikungunya in The British Medical Journal, revealing higher disease burden and substantial costs

Valneva SE Global Health Chikungunya Economic Burden British Medical Journal
BRIEF

published on 11/26/2024 at 17:50, 3 months 18 days ago

Valneva Seeks FDA Approval for Chikungunya Vaccine Expansion

Valneva FDA Application Chikungunya Vaccine Adolescents Antibody Persistence
PRESS RELEASE

published on 11/26/2024 at 17:45, 3 months 18 days ago

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA
Valneva submits label extension application to U.S. FDA for its chikungunya vaccine, IXCHIQ®, to potentially include adolescents aged 12 to 17 years and two-year antibody persistence data

FDA Valneva Chikungunya Vaccine IXCHIQ Label Extension Application
BRIEF

published on 10/10/2024 at 07:05, 5 months 4 days ago

Valneva presents its outlook at an investor day in New York

Investors Growth Valneva Vaccines Lyme

1 2 ... 5

Published on 03/15/2025 at 00:00, 23 minutes ago

BioNxt Solutions Announces Closing of Final Tranche of Fully Subscribed Convertible Debenture Unit Private Placement
Published on 03/14/2025 at 23:20, 1 hour 3 minutes ago

Organto Foods Provides Update on Strategic Plans
Published on 03/14/2025 at 22:55, 1 hour 28 minutes ago

Alset AI Announces Filing of Audited Financial Statements
Published on 03/14/2025 at 21:59, 2 hours 24 minutes ago

Apex Critical Metals Corp. Announces Grant of Stock Options
Published on 03/14/2025 at 21:58, 2 hours 25 minutes ago

Reyna Silver Announces Final Tranche Closing of Previously Announced Non-Brokered Private Placement

View all ACCESSWIRE

Published on 03/14/2025 at 20:20, 4 hours 2 minutes ago

EQS-Adhoc: Gläubigerversammlung zur Anleihenverlängerung
Published on 03/14/2025 at 18:44, 5 hours 38 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/14/2025 at 18:02, 6 hours 20 minutes ago

Form 8.1(c) - Dalata Hotel Group PLC:
Published on 03/14/2025 at 17:55, 6 hours 27 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 03/14/2025 at 16:12, 8 hours 10 minutes ago

Thalassa Holdings Ltd: Trading Update

View all EQS

Published on 03/14/2025 at 18:55, 5 hours 27 minutes ago

Availability of ENGIE's 2024 Universal Registration Document
Published on 03/14/2025 at 18:00, 6 hours 23 minutes ago

Availability of the 2024 Universal Registration Document of OPmobility SE
Published on 03/14/2025 at 16:55, 7 hours 27 minutes ago

Closing of the agreement between ENGIE and the Belgian government
Published on 03/14/2025 at 11:34, 12 hours 48 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as at February 28, 2025
Published on 03/14/2025 at 08:44, 15 hours 39 minutes ago

Aéroports de Paris SA - €1bn dual-tranche new bond issue

View all LES ECHOS COMFI WIRE

News